Interferon-γ-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine
Authors:
- 1 May 2005
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 85 (5) , 655-663
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody TherapyJournal of Experimental Medicine, 2002
- Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamineCarcinogenesis, 1999
- Interferon γ induces differential upregulation of α and β chemokine secretion in colonic epithelial cell linesGut, 1998
- Interspecies comparison of liver carcinogenesis: implications for cancer risk assessmentCarcinogenesis, 1997
- N-Nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-adduct formation, mutagenicity, and tumor initiationPharmacology & Therapeutics, 1996
- Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.Proceedings of the National Academy of Sciences, 1994
- Hepatocellular Carcinoma: Recent ProgressHepatology, 1992
- Hepatocellular Carcinoma in Italian Patients with CirrhosisNew England Journal of Medicine, 1991
- Expression of p53 mutant protein(s) in diethylnitrosamine-induced foci of enzyme-altered hepatocytes in male Fischer-344 ratsCarcinogenesis, 1991
- Correlated increase of the expression of the c-ras genes in chemically induced hepatocarcinomasBiochemical and Biophysical Research Communications, 1984